144 related articles for article (PubMed ID: 37799372)
1. Vegetative plaque on the left superior eyelid.
Wikholm CG; Thakker S; Bakhshi PR; Swigost AJ; Moshell A; Cardis MA
Skin Health Dis; 2023 Oct; 3(5):e277. PubMed ID: 37799372
[TBL] [Abstract][Full Text] [Related]
2. Aggressive Primary Cutaneous Anaplastic T-Cell Lymphoma Successfully Treated with Autologous Stem Cell Transplant and Brentuximab Vedotin Consolidation: Case Report and Review of the Literature.
Guarnera L; Meconi F; Pocci M; Esposito F; Rizzo M; Rapisarda VM; Zizzari A; Di Raimondo C; Pupo L; Anemona L; Cantonetti M
Hematol Rep; 2022 Mar; 14(2):61-66. PubMed ID: 35466174
[TBL] [Abstract][Full Text] [Related]
3. CD30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma.
Liu HL; Hoppe RT; Kohler S; Harvell JD; Reddy S; Kim YH
J Am Acad Dermatol; 2003 Dec; 49(6):1049-58. PubMed ID: 14639383
[TBL] [Abstract][Full Text] [Related]
4. Primary Cutaneous CD8(+) CD30(+) Anaplastic Large Cell Lymphoma: An Unusual Case with a High Ki-67 index-A Short Review.
Nasit JG; Patel SC
Indian J Dermatol; 2015; 60(4):373-7. PubMed ID: 26288406
[TBL] [Abstract][Full Text] [Related]
5. Spectrum of CD30+ lymphoid proliferations in the eyelid lymphomatoid papulosis, cutaneous anaplastic large cell lymphoma, and anaplastic large cell lymphoma.
Sanka RK; Eagle RC; Wojno TH; Neufeld KR; Grossniklaus HE
Ophthalmology; 2010 Feb; 117(2):343-51. PubMed ID: 19969358
[TBL] [Abstract][Full Text] [Related]
6. Combined Modality Treatment With Brentuximab Vedotin and Radiation Therapy for Primary Cutaneous Anaplastic Large Cell Lymphoma: A Case Report.
Floyd EG; Burns TF; Linos K; LeBlanc RE; Carter JB; Jarvis LA; Lansigan F
J Hematol; 2019 Sep; 8(3):132-136. PubMed ID: 32300458
[TBL] [Abstract][Full Text] [Related]
7. CD8-positive primary cutaneous anaplastic large T-cell lymphoma (PCALCL): case report and review of this unusual variant of PCALCL.
Plaza JA; Ortega P; Lynott J; Mullane M; Kroft S; Olteanu H
Am J Dermatopathol; 2010 Jul; 32(5):489-91. PubMed ID: 20442639
[TBL] [Abstract][Full Text] [Related]
8. Long-term Follow-up of a Case of Lymphomatoid Papulosis with a Benign Course.
Balić A; Bartolić L; Ilić I; Radoš J
Acta Dermatovenerol Croat; 2018 Oct; 26(3):264-266. PubMed ID: 30390731
[TBL] [Abstract][Full Text] [Related]
9. CD30-Positive Lymphoproliferative Disorders.
Nikolaenko L; Zain J; Rosen ST; Querfeld C
Cancer Treat Res; 2019; 176():249-268. PubMed ID: 30596222
[TBL] [Abstract][Full Text] [Related]
10. Primary Cutaneous Anaplastic Large Cell Lymphoma (pcALCL) in the Elderly and the Importance of Sport Activity Training.
Sica A; Vitiello P; Ronchi A; Casale B; Calogero A; Sagnelli E; Costa Nachtigal G; Troiani T; Franco R; Argenziano G; Moscarella E; Sagnelli C
Int J Environ Res Public Health; 2020 Jan; 17(3):. PubMed ID: 32013101
[TBL] [Abstract][Full Text] [Related]
11. Complete remission of primary cutaneous anaplastic large cell lymphoma after a short course of brentuximab vedotin.
Milan E; Miceli P; Sernicola A; Finotto S; Marino D; Alaibac M
Mol Clin Oncol; 2021 Jun; 14(6):121. PubMed ID: 33936594
[TBL] [Abstract][Full Text] [Related]
12. Primary cutaneous CD30+ anaplastic large cell lymphoma: report of a rare case.
Chao-Lo MP; King-Ismael D; Lopez RA
J Dermatol Case Rep; 2008 Oct; 2(3):31-4. PubMed ID: 21886709
[TBL] [Abstract][Full Text] [Related]
13. Primary Cutaneous Anaplastic Large Cell Lymphoma With Gastric Metastasis.
Khrais A; Abboud Y; Le A; Patel P; Vossough-Teehan S
Cureus; 2022 Dec; 14(12):e32922. PubMed ID: 36699770
[TBL] [Abstract][Full Text] [Related]
14. Characterization of primary cutaneous CD8+/CD30+ lymphoproliferative disorders.
Martires KJ; Ra S; Abdulla F; Cassarino DS
Am J Dermatopathol; 2015 Nov; 37(11):822-33. PubMed ID: 26485239
[TBL] [Abstract][Full Text] [Related]
15. [Primary cutaneous anaplastic CD30+ large cell lymphoma].
Marrero-Calvo MD; Rodríguez-Serna M; Castejón-Calvete P; Peláez-Malagón S
Actas Dermosifiliogr; 2007 Apr; 98(3):194-7. PubMed ID: 17504705
[TBL] [Abstract][Full Text] [Related]
16. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders.
Yamaguchi T; Ohshima K; Karube K; Kawano R; Nakayama J; Suzumiya J; Kikuchi M
Br J Dermatol; 2006 May; 154(5):904-9. PubMed ID: 16634894
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous anaplastic large-cell lymphoma of the eyelid: report of two cases and review of the literature.
Iuliano A; Fossataro F; Laezza MP; Lanni V; Mascolo M; Varricchio S; Uccello G; Tranfa F; Strianese D
Orbit; 2021 Dec; 40(6):481-487. PubMed ID: 32998605
[TBL] [Abstract][Full Text] [Related]
18. Brentuximab Vedotin for Patients With Refractory Lymphomatoid Papulosis: An Analysis of Phase 2 Results.
Lewis DJ; Talpur R; Huen AO; Tetzlaff MT; Duvic M
JAMA Dermatol; 2017 Dec; 153(12):1302-1306. PubMed ID: 28980004
[TBL] [Abstract][Full Text] [Related]
19. Brentuximab vedotin plus bendamustine in relapsed or refractory Hodgkin's lymphoma: an international, multicentre, single-arm, phase 1-2 trial.
O'Connor OA; Lue JK; Sawas A; Amengual JE; Deng C; Kalac M; Falchi L; Marchi E; Turenne I; Lichtenstein R; Rojas C; Francescone M; Schwartz L; Cheng B; Savage KJ; Villa D; Crump M; Prica A; Kukreti V; Cremers S; Connors JM; Kuruvilla J
Lancet Oncol; 2018 Feb; 19(2):257-266. PubMed ID: 29276022
[TBL] [Abstract][Full Text] [Related]
20. A new era for cutaneous CD30-positive T-cell lymphoproliferative disorders.
Kempf W
Semin Diagn Pathol; 2017 Jan; 34(1):22-35. PubMed ID: 27993440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
